Cybin Inc. (NEO: CYBN)
Canada
· Delayed Price · Currency is CAD 16.50
+1.08 (7.00%)
Nov 15, 2024, 10:39 AM EST
Cybin Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
50
Market Cap
332.33M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | - | - | - |
| Mar 31, 2021 | 864.00K | - | - |
| Mar 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCybin News
- 3 days ago - Cybin to Present 12-Month Phase 2 Data for CYB003 in Major Depressive Disorder on November 18, 2024 - Business Wire
- 4 days ago - Cybin reports Q2 results - Seeking Alpha
- 4 days ago - Cybin Inc. Begins Phase 3 Trials, Betting Big On CYB003 To Treat Depression - Benzinga
- 4 days ago - Cybin Initiates PARADIGM: A Multinational Pivotal Phase 3 Program Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder and Reports Second Quarter Financial Results - Business Wire
- 14 days ago - Cybin Inc: Another High-Risk Psychedelics Play - Seeking Alpha
- 17 days ago - Cybin to Participate at the 2024 Milken Institute Future of Health Summit - Business Wire
- 24 days ago - Cybin Announces Grant of First U.S. Composition of Matter Patent in Support of its CYB005 Phenethylamines Program - Business Wire
- 4 weeks ago - Undercovered Dozen: Endava, Cross Country Healthcare, Cybin, Equinor + - Seeking Alpha